MedTrace Logo

How to Carry on an Effective Community Program of Exercice-oncology.

NCT05078216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 405

Last updated 2021-10-14

No results posted yet for this study

Summary

Exercise-oncology is an emerging area, but exist a lack of information about an effective methodology to establish counseling programs long-lasting and not based on research objectives. This observational study objective was to evaluate the feasibility and effective exercise-oncology community intervention in a real patients sample.

Conditions

  • Cancer Patients in Different Stages

Interventions

OTHER

Physical exercise intervention

12-week supervised intervention, 90 minutes sessions twice per week All sessions had the same structure: 10 min of warm-up at 60-70% maximal heart rate (MHR), followed by 60-70 minutes of specific training and 10 minutes of stretching exercises. At least, 20% of the total session time was based on cardiovascular work over 70% of the maximum heart rate (MHR). Fitness work in the first eight sessions was planned following 30 min of time on cardiovascular exercise 55 min on work out in low to moderate intensity. In the next eight sessions, the time spent on cardiovascular work was slightly increased to 35 min, with 50 min focused on work out, combining moderate to high-intensity sessions. The last eight sessions presented the same structure as the first ones but combining moderate to high intensity.

Sponsors & Collaborators

  • Asociación Española contra el Cáncer

    lead OTHER

Principal Investigators

  • Soraya Casla Barrio, Phd · Asociación Española contra el Cáncer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2020-03-13
Completion
2020-03-13

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05078216 on ClinicalTrials.gov